Skip to content
Search AI Powered

Latest Stories

A New Dawn for NYC Cannabis Businesses As Gov. Hochul Provides Tax Relief

New York’s governor, Kathy Hochul, signed groundbreaking legislation providing much-needed tax relief to New York City marijuana businesses, a significant move in a landscape where federal deductions under Internal Revenue Service (IRS) code 280E are currently off-limits.

NY's Cannabis Industry Gets Some Tax Relief Thanks to Gov. Hochul
NY's Cannabis Industry Gets Some Tax Relief Thanks to Gov. Hochul

New York’s governor, Kathy Hochul, has recently signed groundbreaking legislation providing much-needed tax relief to New York City marijuana businesses, a significant move in a landscape where federal deductions under Internal Revenue Service (IRS) code 280E are currently off-limits. This decisive action comes after a five-month wait following the Senate and Assembly’s approval of the proposal, underscoring the state’s commitment to supporting the burgeoning cannabis industry, according to Marijuana Moment.

The legislation represents a pivotal step in addressing the unique tax challenges faced by cannabis businesses. Historically, these entities have been hamstrung by federal policies that severely limit their ability to make standard business deductions. The new law seeks to bridge this gap at the city level, following a similar state-level initiative included in last year's separate budget bill. However, New York City’s distinct tax laws remained unaffected by the earlier state-level change, necessitating this targeted intervention.


Specifically, the new measure allows cannabis businesses to deduct expenses related to the sale, distribution, or production of adult-use cannabis products or medical cannabis for the unincorporated business tax (UBT), the general corporation tax (GCT), and the corporate tax of 2015, commonly referred to as the business corporation tax (BCT). This change aligns the city’s tax policies more closely with New York State law, which recognizes and supports these businesses akin to any other legitimate enterprise.

In practical terms, the city’s tax code will be amended to permit deductions equivalent to those denied under section 280E of the federal internal revenue code. This adjustment acknowledges the unique status of cannabis-related businesses, which, while unable to claim federal tax deductions, are nonetheless legal and encouraged under New York law. The bill’s memo highlights this rationale, emphasizing the need for city business taxes to foster these activities.

This legislative reform, backed by New York City Mayor Eric Adams, reflects a broader trend across various states. As federal marijuana reform continues to stall in Congress, leaving state-licensed cannabis businesses facing disproportionately high federal tax rates, states are stepping up. New York joins the ranks of Pennsylvania, Maine, Illinois, Connecticut, and New Jersey, all of which have recently enacted similar measures to provide state-level tax relief to cannabis businesses. These initiatives represent a patchwork of solutions to a federal problem, with states increasingly acting independently to support their legal cannabis industries.

In May, Rep. Earl Blumenauer (D-OR) reintroduced a bill aimed at amending the IRS code, a move that would enable state-legal marijuana businesses to take federal tax deductions like those available to other industries. Blumenauer's efforts highlight the growing recognition of the incongruities in current tax laws and the need for federal action. However, until such federal reforms are enacted, the cannabis industry continues to navigate a complex and often contradictory tax landscape.

The IRS has offered limited guidance on the application of Section 280E, a gap that was somewhat addressed in a 2020 update. This update clarified that cannabis businesses, while restricted from standard deductions, can reduce their gross receipts by properly calculated costs of goods sold to determine gross income. This guidance came in response to a Treasury Department internal watchdog report criticizing the IRS for insufficiently advising marijuana industry taxpayers about compliance with federal tax laws.

An overarching resolution to the industry’s 280E problem could emerge if the Drug Enforcement Administration (DEA) heeds the recommendation of the U.S. Department of Health and Human Services (HHS) to reclassify marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). Such a reclassification would not only address tax issues but also herald a significant shift in the federal government's stance on cannabis.

In conclusion, New York City's recent legislation marks a vital step in addressing the disproportionate tax burden on cannabis businesses. It reflects a growing awareness and acceptance of the cannabis industry's legitimacy and the need for equitable tax treatment.

As states like New York take the lead, the pressure mounts on the federal government to enact comprehensive reforms, harmonizing tax laws with the evolving landscape of cannabis legalization and commerce.

More For You

Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less
Lights, Camera, Cannabis: The New Theater Experience
Cigar smoking in a bar....
Giphy

NY Movie Theaters: High on Cannabis Lounges

In the dimly lit ambiance of New York City's historic movie theaters, the scent of buttered popcorn has long been the olfactory hallmark. However, as cannabis legalization sweeps across the state, a provocative question emerges: Could the future of cinema include the aroma of cannabis alongside the traditional concessions?

The Current Landscape of Cannabis Consumption Lounges

New York State’s Clean Indoor Air Act (CIAA) casts a long shadow over this budding idea. Enacted to safeguard public health, the CIAA prohibits smoking and vaping in most indoor workplaces, encompassing bars, restaurants, and, notably, movie theaters. The act defines smoking expansively, including the burning of tobacco, cannabis, or cannabinoid-hemp products. Violations can result in fines up to $2,000 for each infraction, underscoring the state’s commitment to maintaining smoke-free public spaces.

Keep ReadingShow less
Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
Talking Joints Memo - Chris Faraone
Talking Joints Memo - Chris Faraone

Massachusetts State Lawmakers Release Scathing Critique of MA's Cannabis Control Commission

By Chris Faraone, Talking Joints Memo. Reprinted with permission from Talking Joints Memo. .

“The public deserves some accountability on why these issues have proven so hard to stamp out, and what long-term changes the agency is making to get its work done with more transparency and efficiency.”

There has been endless drama around the Massachusetts Cannabis Control Commission over the past few months, all of which is only heightening in the wake of state Treasurer Deb Goldberg suspending the agency’s chairwoman last week.

Keep ReadingShow less
What's Going on With New York's Legal Cannabis Rollout
What's Going on With New York's Legal Cannabis Rollout

What’s Going on with New York’s Legal Cannabis Roll Out? 

The New York cannabis industry is facing a complex and challenging landscape as it transitions from a medical marijuana program to a fully legal recreational market. Despite the recent legalization of adult-use cannabis in the state, there are still many issues to be addressed, including regulatory compliance, licensing, distribution, capital and equity concerns, and of course, litigation.

Recently, several lawsuits have been filed against the New York State Cannabis Control Board (CCB) and the Office of Cannabis Management (OCM), which are the agencies responsible for overseeing the state's cannabis industry.

Keep ReadingShow less